• img1

Our Products & Services

Stago Offers the Only Commercially Available Monoclonal Antibodies Anti-Human GPVI

2014/09/25: Glycoprotein VI (GPVI), a major collagen receptor playing a crucial role in collagen-induced platelet activation and aggregation, is a ~62-kDA type 1 transmembrane receptor belonging to the immunoglobulin superfamily.

Stago Receives Advanced Clearance for STA®-Liatest® D-Di from US FDA

September 9, 2014 US FDA has cleared STA®-Liatest® D-Di for the exclusion of the diagnosis of PE. STA®-Liatest® D-Di is the first high-sensitivity, rapid, automated D-Dimer assay that receives clearance with a clinical study design compliant with the latest and most stringent guidelines on the subject published by the Clinical Laboratory Standards Institute (CLSI), H59-A.

Educational Resources from Diagnostica Stago: The Hemostasis Experts

September 9, 2013, Parsippany, NJ, USA – Diagnostica Stago Inc., offers expertise through two free electronic resources to educate healthcare professionals on hemostasis and thrombosis. The Stago-EdVantage web site and iHemOStasis app for the Apple® iPad® both offer ways to increase hemostasis knowledge, understand clinical situations, therapies and detection methods, and apply practical skills to patient care.

Haemtech Biopharma Services validates first Thrombin Generation assay for commercial IVIG product release

December 2013 - Essex Junction, Vermont – Haemtech Biopharma Services (HBS) is pleased to announce the successful validation of a thrombin generation assay (TGA) for an IVIG drug. The assay was validated in 2012 to support the use of TGA as a release assay for Biotest Pharmaceuticals Corporation’s U.S. Food and Drug Administration Biologics License Application for BIVIGAM® [Immune Globulin Intravenous (Human), 10% L...

Stago Expands Utility of STA® - Liquid Anti-Xa with Launch of Apixaban Calibrators and Controls for Research Use

January 2014, Parsippany, NJ, USA – Diagnostica Stago Inc. announces launch of STA® – Apixaban Calibrator and Controls for use with the STA® - Liquid Anti-Xa assay (catalog #s 00311US and 00322US). The bar-coded, automation-ready calibrators and controls expand the utility of STA® - Liquid Anti-Xa for specific measurement of apixaban activity in plasma for research purposes. The chromogenic STA® - Liquid Anti-Xa wit...

Our Strengths

Stago in US

Diagnostica Stago, Inc., (DSI) is an industry leader in the science of hemostasis and thrombosis. Stago provides the total commitment of global resources and responsiveness, coupled with cutting edge technology and reliability. DSI is dedicated to continually developing and providing the very best hemostasis products, technical support, and services.

stago MSDSContinuing Educationcorporate videoclarityStago International Webinarstcoag MSDS

Our Commitment

At Stago, we work hard everyday to ensure we are providing best-in-class products and services for the benefit of our laboratory professional customers and the hemostasis community.  We consistently improve our products and services to meet the demands of the ever changing laboratory landscape.  Stago is proud to announce that for the second year in a row it has won the Northface Award for Customer Service Excellence by the Omega Management Group.

Events

All Events

iPad app

This Ouvre un lien externe dans la fenêtre courantefree educational application in English is the first of its kind and has been developed by an expert in Haemostasis… Stago.

Understanding Hemostasis

Did you know?

Heparin was discovered independently in 1911 by Doyon and in 1916 by McLean, for different reasons. The effect of heparin on blood clotting, however, had been observed one-third of a century earlier.

Contact us | Credits and copyrights | Terms of Use | Privacy Policy | Site map |